Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome
出版年份 2023 全文链接
标题
Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome
作者
关键词
-
出版物
Metabolites
Volume 13, Issue 11, Pages 1130
出版商
MDPI AG
发表日期
2023-11-05
DOI
10.3390/metabo13111130
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pathophysiology of obesity and its associated diseases
- (2023) Xin Jin et al. Acta Pharmaceutica Sinica B
- Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
- (2023) Olufunto O. Badmus et al. CURRENT HYPERTENSION REPORTS
- Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
- (2022) Yamei Duan et al. Frontiers in Immunology
- Adipose tissue and insulin resistance in obese
- (2021) Bulbul Ahmed et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of Insulin Resistance in MAFLD
- (2021) Yoshitaka Sakurai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
- (2021) Revathy Carnagarin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19
- (2021) Liam Rose et al. Frontiers in Medicine
- MH-76, a Novel Non-Quinazoline α1-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats
- (2021) Monika Kubacka et al. Pharmaceuticals
- Imbalanced GSH/ROS and sequential cell death
- (2021) Ting Liu et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence
- (2021) Sandra A. Serna-Salas et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
- (2021) Karolina Drożdż et al. Nutrients
- The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
- (2021) Siyu Yu et al. Frontiers in Pharmacology
- Histamine H3 Receptor Ligands—KSK-59 and KSK-73—Reduce Body Weight Gain in a Rat Model of Excessive Eating
- (2021) Kamil Mika et al. Pharmaceuticals
- α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
- (2020) Ute A. Schwinghammer et al. Cells
- Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity
- (2020) Satoshi Yoshino et al. Scientific Reports
- Quinazoline alpha-adrenoreceptor blockers as an adjunct cancer treatment: From bench to bedside
- (2020) Liam King et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist
- (2019) Monika Kubacka et al. HYPERTENSION RESEARCH
- The liver as an endocrine organ - linking NAFLD and insulin resistance
- (2019) Matthew J Watt et al. ENDOCRINE REVIEWS
- Beneficial effects of non-quinazoline α1-adrenolytics on hypertension and altered metabolism in fructose-fed rats. A comparison with prazosin
- (2019) Monika Kubacka et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The role of thiols in antioxidant systems
- (2019) Kathrin Ulrich et al. FREE RADICAL BIOLOGY AND MEDICINE
- The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
- (2019) Gniewomir Latacz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Hepatic Central Vein: Structure, Fibrosis, and Role in Liver Biology
- (2019) Ki M. Mak et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Rodent Models of Nonalcoholic Fatty Liver Disease
- (2019) Fang Zhong et al. DIGESTION
- Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
- (2019) Thomas Marjot et al. ENDOCRINE REVIEWS
- Dietary Fructose and the Metabolic Syndrome
- (2019) Taskinen et al. Nutrients
- High fructose diet-induced metabolic syndrome: Pathophysiological mechanism and treatment by traditional Chinese medicine
- (2018) Ying Pan et al. PHARMACOLOGICAL RESEARCH
- Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake
- (2018) Sabine Thuy et al. JOURNAL OF NUTRITION
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
- (2017) et al. Nutrients
- Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
- (2017) Qian Chen et al. Nutrients
- Combination with Red ginseng and Polygoni Multiflori ameliorates highfructose diet induced metabolic syndrome
- (2016) Min Chul Kho et al. BMC Complementary and Alternative Medicine
- Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion
- (2016) Martin Humberto Muñoz-Ortega et al. Gut and Liver
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Doxazosin Stimulates Galectin-3 Expression and Collagen Synthesis in HL-1 Cardiomyocytes Independent of Protein Kinase C Pathway
- (2016) Xiaoqian Qian et al. Frontiers in Pharmacology
- Protective effect of crocetin against burn-induced intestinal injury
- (2015) Chunxiang Zhou et al. JOURNAL OF SURGICAL RESEARCH
- Effects of acetylsalicylic acid on the levels of sulfane sulfur and non-protein sulfhydryl groups in mouse tissues
- (2014) Anna Bilska-Wilkosz et al. Pharmacological Reports
- Effects of Dipeptidyl-Peptidase 4 Inhibitor about Vascular Inflammation in a Metabolic Syndrome Model
- (2014) Nicolas F. Renna et al. PLoS One
- Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver
- (2014) Salamah Mohammad Alwahsh WORLD JOURNAL OF GASTROENTEROLOGY
- Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2014) Yoshihisa Takahashi WORLD JOURNAL OF GASTROENTEROLOGY
- Tamarind seed extract mitigates the liver oxidative stress in arthritic rats
- (2014) Mahalingam Shanmuga Sundaram et al. Food & Function
- Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
- (2013) Verena Wieser et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis
- (2013) Chad McKee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Carvedilol Attenuates the Progression of Alcohol Fatty Liver Disease in Rats
- (2012) Jinyao Liu et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease
- (2010) Sweta Tandra et al. JOURNAL OF HEPATOLOGY
- Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?
- (2010) Neil Chapman et al. JOURNAL OF HYPERTENSION
- Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects
- (2008) Kevin M. Korenblat et al. GASTROENTEROLOGY
- Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism
- (2008) Laia Vilà et al. HEPATOLOGY
- Metabolism of prazosin in rat and characterization of metabolites in plasma, urine, faeces, brain and bile using liquid chromatography/mass spectrometry (LC/MS)
- (2008) J. C. L. Erve et al. XENOBIOTICA
- α1-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice
- (2007) L E Randle et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now